CD 98 , a potential diagnostic cancer-related biomarker , and its prognostic impact in colorectal cancer patients

Ying Ye,Miao Wang,Bin Wang,Yu Li,Xiang-Min Yang,Zhi-Nan Chen

2017-01-01

Abstract:Background: Successive discoveries in recent years suggested CD98 played an extensive and significant role due to its high levels in human diseased or normal tissues. The current study concentrated on exploring CD98 expression in different cancer and its potential application in diverse clinical settings including risk assessment, detection and localization as a cancer-associated biomarker. Methods: We evaluated the protein expression levels of CD98 in 15 TMAs and 100 samples of histologically confirmed CRC tissues and analyzed the relationships between their expression levels, clinicopathological parameters and their prognostic significance. Results: On immunohistochemical analysis of 15 TMAs with 713 samples of carcinoma tissues and 260 samples of normal or cancer adjacent normal tissues, CD98 was expressed in carcinoma with an overall positivity rate of 74%, which was significantly higher than that in adjacent normal or normal tissues (41%, P < 0.0001). In addition, a retrospective study of pathological sections of 100 matched pairs of normal and tumor tissues from patients confirmed diagnoses of CRC demonstrated CD98 expression had clinicopathological significance, and the differential expression in colorectal carcinoma and adjacent normal tissues was also found at the mRNA level (P < 0.001). CD98 expression level significantly correlated with tumor size, clinical stage, tumor grading, T factor, N factor, distant metastasis (all P < 0.05). Univariate analysis confirmed that tumor size, clinical stage, tumor grading, T factor, N factor, distant metastasis and CD98 expression level (all P < 0.05). Cox regression analysis indicated CD98 was an independent prognostic factor for OS (HR=0.307, 95% CI=0.168-0.560, P < 0.001) in CRC. Conclusions: CD98 was significantly expressed in various cancers and appears to have prognostic significance, suggesting it a possible cancer-associated biomarker for pathological diagnosis, prognostic evaluation and targeted therapy of a broad range of cancer types. In addition, CD98 expression was positively correlated with poor prognosis and was an independent prognostic factor in colorectal cancer patients. CD98 may be a potential target for improving treatments for CRC.